Oncolytic Virus Cancer Therapy Pipeline, 2022: Insights into the Clinical and Non-Clinical Trials, Current Therapies, Emerging Drugs | Key Companies – Transgene, Targovax, DNAtrix, Astellas, Nouscom
The Oncolytic Virus Cancer Therapy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase.
The report also covers a detailed description of the drug including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers, acquisition, funding, designations, and other product-related details.
Oncolytic Virus Cancer Therapy Pipeline Analysis
The report provides insights into:
-
The report provides detailed insights about companies that are developing Oncolytic Virus Cancer Therapy.
-
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development.
-
Oncolytic Virus Cancer Therapy key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
-
Oncolytic Virus Cancer Therapy under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
-
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Oncolytic Virus Cancer Therapy market.
The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Request for Sample PDF Report – https://www.delveinsight.com/sample-request/oncolytic-virus-cancer-therapy-pipeline-insight-2021
Oncolytic Virus Cancer Therapeutics Landscape
Oncolytic virus (OV) cancer therapies are virus-based therapeutic strategies that infect and destroy cancer cells and therefore act as an in situ cancer vaccine by releasing tumor-specific antigens. Viruses such as myxoma virus or reovirus have inherent selectivity to tumor cells while being nonpathogenic to healthy human cells.
Oncolytic Virus Cancer Therapies covered in the report include:
-
NOUS PEV
-
ASP 9801
-
DNX-2401
-
ONCOS 102
-
TG 6002
-
Pelareorep
-
CG0070
And many more
Some of the key companies in the Oncolytic Virus Cancer Therapy Market include:
-
CG Oncology
-
Oncolytics Biotech
-
Transgene
-
Targovax
-
DNAtrix
-
Astellas Pharma
-
Nouscom
And many others
Get More Detailed Insights Into the Emerging Therapies & Key Companies – https://www.delveinsight.com/sample-request/oncolytic-virus-cancer-therapy-pipeline-insight-2021
Table of Content (TOC)
1. Report Introduction
2. Executive Summary
3. Oncolytic Virus Cancer Therapy Current Treatment Patterns
4. Oncolytic Virus Cancer Therapy – DelveInsight’s Analytical Perspective
5. Therapeutic Assessment
6. Oncolytic Virus Cancer Therapy Late Stage Products (Phase-III)
7. Oncolytic Virus Cancer Therapy Mid-Stage Products (Phase-II)
8. Oncolytic Virus Cancer Therapy Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Oncolytic Virus Cancer Therapy Discontinued Products
13. Oncolytic Virus Cancer Therapy Product Profiles
14. Key Companies in the Oncolytic Virus Cancer Therapy Market
15. Key Products in the Oncolytic Virus Cancer Therapy Therapeutics Segment
16. Dormant and Discontinued Products
17. Oncolytic Virus Cancer Therapy Unmet Needs
18. Oncolytic Virus Cancer Therapy Future Perspectives
19. Oncolytic Virus Cancer Therapy Analyst Review
20. Appendix
21. Report Methodology
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF Report – https://www.delveinsight.com/sample-request/oncolytic-virus-cancer-therapy-pipeline-insight-2021
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Other Trending Healthcare Reports by DelveInsight
Bone Neoplasms Market
“Bone Neoplasms Market” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Bone Neoplasms market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
